ASCENT-GYN-01 | CT06486441

Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy. Contact: trials@anzgog.org.au

ASCENT-GYN-01 | CT064864412026-06-24T22:18:27+10:00

GLORIOSA | NCT05445778

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer. Contact: GLORIOSA@anzgog.org.au 

GLORIOSA | NCT054457782026-06-24T22:21:40+10:00
Go to Top